✦ LIBER ✦
FEC (5-fluorouracil, epidoxorubicin and cyclophosphamide) versus EM (epidoxorubicin and mitomycin-C) with or without lonidamine as first-line treatment for advanced breast cancer. A multicentric randomised study. Final results
✍ Scribed by P. Pacini; M. Rinaldini; R. Algeri; A. Guarneri; E. Tucci; G. Barsanti; B. Neri; P. Bastiani; S. Marzano; C. Fallai
- Book ID
- 117656812
- Publisher
- Elsevier Science
- Year
- 2000
- Tongue
- English
- Weight
- 205 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.